|
Mr. Gury is the former Chairman and CEO of NABI Biopharmaceuticals. In May 1984, Mr. Gury joined NABI Biopharmaceuticals as President and Chief Operating Officer. He was elected Chairman of the Board, Chief Executive Officer and President in April 1992. During his tenure, the Company successfully transitioned from a plasma supplier into a fully integrated biopharmaceutical company.
Prior to joining NABI Biopharmaceuticals, Mr. Gury spent his career with Abbott Laboratories in various administrative and executive positions and with Alpha Therapeutics Corporation, a spin out from Abbott.
Mr. Gury completed his A.B. in economics at Kenyon College, Gambier, Ohio, in 1960 and received his MBA at the University of Chicago in 1962, specializing in accounting and finance. His undergraduate junior year was spent at the University of Madrid in Spain. He was a Research Fellow at the University of Chicago and an intern with Arthur Anderson & Co.
David is Chairman of the Florida Research Consortium; and past Chairman and a member of BioFlorida.
| 